The need for prognosticators in rheumatoid arthritis. Biological and clinical markers: where are we now?
Josef S Smolen, Daniel Aletaha, Johannes Grisar, Kurt Redlich, Günter Steiner, Oswald Wagner
Arthritis Research & Therapy 2008 10:208
|
| Access to the full text of this article requires a subscription (the abstract is freely accessible) | |  Existing subscribers login |
Arthritis Research & Therapy publishes the latest mechanism-defining research and analysis relating to the rationale and treatment of arthritis, autoimmune disease and diseases of bone and cartilage. This highly cited journal has an Impact Factor of 4.04.
Arthritis Research & Therapy publishes:
- Reviews including full, factual accounts of recent developments
- Commentaries discussing issues from recently published articles, or areas currently under discussion
- Peer-reviewed basic and translational research articles
You can:
- Register with Arthritis Research & Therapy for regular, customized email alerts and stored search results.
|
If you are registered and have trouble logging in, email us: info@arthritis-research.com |
